% | $
Quotes you view appear here for quick access.

Infinity Pharmaceuticals, Inc. (INFI) Message Board

  • josephbiough939 josephbiough939 Dec 7, 2013 12:34 PM Flag

    73% ORR up 20% from June's data is unbelievable!!!

    20% CRR!!!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree that the data looks very good in iNHL, better than Gilead's and there is no Ibrutinib in iNHL. On the CLL front is a tad disappointing in terms of efficacy, as it is lagging GILD or Pharmacyclics data, although INFI's nodal response can turn into PR or CRs in later followups. Fortunately, side effect profile is cleaned up with antibiotics prophylaxis, although docs will still need to monitor neutropenia. Let's say the drug can do $300-500mm annual sales on CLL and iNHL combined, which means INFI should trade at $1.5b market cap...let's hope the market reflects that tomorrow

1.63+0.04(+2.52%)Aug 25 4:00 PMEDT